Let us pay you to watch comedy by providing you with a recap of the previous night’s best bits on Best of Late Night. Here are Netflix’s top 50 current offerings.
If it’s the Third Time Lucky,
It is expected that the White House will recommend that Americans receive coronavirus booster injections eight months after their initial vaccination.
Fallon joked on Tuesday night that the White House is hiring a movie trailer narrator to say, “This fall, Pfizer completes their epic trilogy,” to help sell the idea to American citizens.
The Best Parts of the Show
Julie Bowen, a guest on “Jimmy Kimmel Live,” described how she and her family helped an injured hiker in a national park on Tuesday’s episode.
Wednesday Night Plans: What We’re Excited About
Jimmy Fallon and Michael Keaton will reunite on the “Tonight Show” on Wednesday.
The FDA will Soon Get ata from Pfizer’s third-dose vaccine study.
Pfizer expects to submit data to the FDA on a third dose of its coronavirus vaccine next month, Dolsten said on Wednesday’s results call.
Dolsten added, “We are in continuous negotiations with regulatory agencies considering a potential third-dose booster of the current vaccination, and, assuming positive findings, anticipate an emergency use permission filing as early as August.”
On December 17, 2020, a drive-up vaccination station operated by Renown Health in Reno, Nevada, was stocked with syringes and vials of the Pfizer-BioNTech Covid-19 vaccine in accordance with an emergency use authorization.
It would be necessary for the FDA to change the emergency use authorization it provided for the vaccine or for the vaccine to be fully authorised by the FDA before a third dosage could be given off label in the United States.
As Dolsten pointed out, data suggest that antibody levels appear to decline around eight months after receiving a second dose of vaccine, so it is likely that a third-dose booster may be needed within six to 12 months after full vaccination to maintain the highest level of protection. Studies are currently underway to evaluate the safety and immunogenicity of a third dose.
Dolsten added that, “pending regulatory permission,” a new trial testing the vaccine’s immunogenicity and safety against the Delta variation would begin in August.
The Delta variation, which now accounts for around 83% of sequenced Covid-19 cases in the United States, was cited as the “most transmissible” he has observed.
